Comparative Effectiveness and Safety of ELIOS in Patients With Open-Angle Glaucoma Undergoing Cataract Surgery

Who May Qualify: 1. Male or female subjects. 2. 40 years old or older. 3. Diagnosis of mild to moderate primary open-angle glaucoma, pseudoexfoliation glaucoma or pigmentary glaucoma: 4. Visually significant cataract eligible for phacoemulsification. Who Should NOT Join This Trial: 1. All forms of angle closure glaucoma 2. Secondary glaucoma, including traumatic, neovascular, uveitic, lens-induced, steroid-induced, angle-recession, glaucoma associated with vascular disorders, and glaucoma associated with increased episcleral venous pressure 3. Congenital or developmental glaucoma 4. Prior incisional glaucoma surgery, intraocular surgery or ocular laser treatment of any type with the exception of selective laser trabeculoplasty (SLT) occurring a minimum of 6 months prior to the Screening visit Always talk to your doctor about whether this trial is right for you.